Our Journey


  • 1994

    Establishing of Tabuk Pharmaceuticals, located in Riyadh, Kingdom of Saudi Arabia 

  • 1994

    Establishing the first production site in Tabuk, Kingdom of Saudi Arabia

  • 1997

    Expand our geographical presence to include the Algerian market

  • 1999

    Expand our geographical presence to include markets of United Arab Emirates, Kuwait, Oman, Bahrain, Qatar and Jordan

  • 2004

    Expand our geographical presence to include the Egyptian market

  • 2005

    Establishing a well-developed Corporate Research and Development center in Jordan

  • 2006

    Acquisition of Tabuk Pharmaceuticals by Astra Industrial Group (AIG) as a 100% owned subsidiary

  • 2007

    Establishing a regional office for the Middle East and North Africa in Cairo, Egypt

  • 2010

    Acquisition of Sigma Tau Sudan by Tabuk Pharmaceuticals to strengthen Tabuk Pharmaceuticals presence in North Africa

  • 2015

    Launching a state-of-art new production site in Dammam, Kingdom of Saudi Arabia to be the first ever site in the Kingdom to manufacture lyophilized injectables

  • 2016

    Launching a modern new production site in Blida, Algeria to strengthen Tabuk Pharmaceuticals presence in North Africa